医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.

广告
第一作者: Ignace,Vergote
第一单位: University Hospitals Leuven, Leuven, Belgium; Vlaams Instituut voor Biotechnologie, KU Leuven Center for Cancer Biology, Leuven, Belgium. Electronic address: ignace.vergote@uz.kuleuven.ac.be.
作者单位: University Hospitals Leuven, Leuven, Belgium; Vlaams Instituut voor Biotechnologie, KU Leuven Center for Cancer Biology, Leuven, Belgium. Electronic address: ignace.vergote@uz.kuleuven.ac.be. [1] Medical Oncology, Hospital Clinico Universitario, Valencia, Spain; Grupo Espanol de Investigacion en Cancer Ginecologico (GEICO), Madrid, Spain. [2] Department of Oncology, University of Turin, Turin, Italy; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy. [3] Florida Cancer Specialists and Research Institute, West Palm Beach, Florida, USA; Gynecologic Oncology Group (GOG) Foundation, Philadelphia, Pennsylvania, USA. [4] Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, USA. [5] Charles University and General University Hospital in Prague, Prague, Czech Republic; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic. [6] Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy. [7] NYU Langone Health Perlmutter Cancer Center, New York, New York, USA. [8] Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, Charité-Berlin University of Medicine, Berlin, Germany. [9] Sheba Medical Center, Tel Hashomer, Israel; Tel Aviv University, Tel Aviv, Israel. [10] Women's Cancer Care Associates, LLC, Albany, New York, USA. [11] Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. [12] University Hospitals Leuven, Leuven, Belgium; Gynaecological Oncology, KU Leuven University Hospitals Leuven, Leuven, Belgium. [13] Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. [14] Galway University Hospitals, Galway, Ireland. [15] Frankston Hospital, Frankston and Monash University, Frankston, Victoria, Australia. [16] Department of Oncology, Rigshospitalet; Copenhagen University Hospital, Copenhagen, Denmark. [17] Karyopharm Therapeutics Inc, Newton, Massachusetts, USA. [18] Florida Cancer Specialists and Research Institute, West Palm Beach, Florida, USA; Gynecologic Oncology, Mount Sinai Medical Center, New York, New York, USA. [19] Gynecologic Oncology Group (GOG) Foundation, Prague, Czech Republic; Texas Oncology, Shenandoah, Texas, USA. [20]
关键词 Uterine Cancer
DOI 10.1136/ijgc-2024-005412
PMID 40228946
发布时间 2025-04-16
提交
  • 浏览0
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷